Lifeward Sets Timeline for 2026 Shareholder Meeting
TipRanks (Tue, 15-Sep 5:50 PM ET)
Globe Newswire (Tue, 15-Sep 8:00 AM ET)
Lifeward Publishes Updated Investor Presentation Highlighting Commercial Growth Strategy
Globe Newswire (Tue, 8-Sep 8:30 AM ET)
Globe Newswire (Mon, 31-Aug 4:15 PM ET)
Globe Newswire (Mon, 17-Aug 8:00 AM ET)
Lifeward Reports Strong Second Quarter 2026 Financial Results as Commercial Execution Drives Growth
Globe Newswire (Fri, 14-Aug 9:15 AM ET)
Lifeward to Report Second Quarter 2026 Financial Results on August 14, 2026
Globe Newswire (Fri, 7-Aug 8:00 AM ET)
Globe Newswire (Wed, 5-Aug 8:00 AM ET)
Nano Dimension Announces Appointment of Interim Chief Executive Officer and Chairman of the Board
Globe Newswire (Tue, 21-Jul 4:05 PM ET)
Globe Newswire (Tue, 7-Jul 4:15 PM ET)
Lifeward Ltd is a medical device company that designs, develops, and commercializes life-changing solutions spanning the continuum of care in physical rehabilitation and recovery, delivering functional and health benefits in clinical settings as well as in the home and community. Its product offerings include the ReWalk Personal Exoskeleton, ReStore Exo-Suit, MYOLYN FES Cycling, and AlterG Anti-Gravity Systems. The company operates in the United States, which generates the majority of its revenue, as well as in Europe, Germany, Asia Pacific, and the rest of the world.
Lifeward Ltd. - trades on the NASDAQ stock market under the symbol LFWD.
As of September 15, 2026, LFWD stock price declined to $7.07 with 7,077 million shares trading.
LFWD has a market cap of $20.02 million. This is considered a Sub-Micro Cap stock.
Last quarter Lifeward Ltd. - reported $7 million in Revenue and -$1.46 earnings per share. This fell short of revenue expectation by $-85,400 and missed earnings estimates by -$.14.
The top ETF exchange traded funds that LFWD belongs to (by Net Assets): DCOR, DFAC.
LFWD has underperformed the market in the last year with a price return of +0.7% while the SPY ETF gained +16.4%. However, in the short term, LFWD had mixed performance relative to the market. It has outperformed in the last 3 months, returning +4.3% vs +2.4% return in SPY. But in the last 2 weeks, LFWD shares have been beat by the market, returning -7.6% compared to an SPY return of -1.3%.
LFWD support price is $6.80 and resistance is $7.42 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LFWD shares will trade within this expected range on the day.